Pdl Biopharma (PDLI) 7.28 $PDLI
Momentum Indicators for Biotech Equities - PDL BioPharma, Geron, Celldex Therapeutics, XOMA Corp., and Juno Therapeutics
PR Newswire - Mon Feb 09, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: PDL BioPharma Inc. (NASDAQ: PDLI), Geron Corporation (NASDAQ: GERN), Celldex Therapeutics Inc. (NASDAQ: CLDX), XOMA Corporation (NASDAQ: XOMA), and Juno Therapeutics Inc. (NASDAQ: JUNO). Free research report on PDL BioPharma can be accessed at http://get.Investor-Edge.com/pdf/?c=PDL%20Bio...amp;s=PDLI. On Friday, February 06, 2015, the NASDAQ Composite ended at 4,744.40, down 0.43%, the Dow Jones Industrial Average declined 0.34%, to finish the day at 17,824.29, and the S&P 500 closed at 2,055.47, down 0.34%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 806.81, down 0.84%, while the index has advanced 4.07% in the last three months. Register for your complimentary reports at the links given below.
GERN: 3.03 (unch), CLDX: 20.97 (+0.53), JUNO: 40.52 (+0.18), XOMA: 3.41 (-0.01), PDLI: 7.28 (+0.03)
PDL BioPharma: Beware The 8% Dividend
Dave Dierking, CFA - at Seeking Alpha - Fri Feb 06, 12:07PM CST
BIIB: 391.66 (-0.45), PDLI: 7.28 (+0.03), NVS: 102.20 (-0.17)
6.73% Edge For 5 Healthcare Lowest-Priced, High-Yield January Dividend Dogs
Fredrik Arnold - at Seeking Alpha - Thu Feb 05, 6:43PM CST
SNN: 35.82 (-0.28), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), SNY: 49.42 (+0.82), PDLI: 7.28 (+0.03)
10 Hardy Healthcare Dividend Dogs Hit 20% Mean January Upsides
Fredrik Arnold - at Seeking Alpha - Wed Feb 04, 7:53PM CST
KND: 19.68 (-0.38), BDX: 143.71 (+0.72), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), MR: 27.19 (+0.15), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), TRIB: 17.30 (-0.12), TEVA: 56.77 (-0.58), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
PDL BioPharma to Present at Upcoming Investor Conferences
PR Newswire - Wed Feb 04, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the following upcoming conferences.
PDLI: 7.28 (+0.03)
PDL BioPharma to pay USD0.15 per share dividend per quarter
M2 - Fri Jan 30, 11:15PM CST
The board of directors of PDL BioPharma (NasdaqGS
DLI), a monoclonal antibodies company, declared on Thursday that it will pay a regular, quarterly dividend of USD0.15 per share of its common stock.
PDLI: 7.28 (+0.03)
Buy These Top 3 Buy-Rated Dividend Stocks Today: ENLK, PDLI, KMI
at The Street - Thu Jan 29, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
KMI: 41.97 (+0.21), PDLI: 7.28 (+0.03), ENLK: 28.62 (+0.25)
PDL BioPharma declares $0.15 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 6:22AM CST
PDLI: 7.28 (+0.03)
PDL BioPharma Announces 2015 Regular Quarterly Dividends
PR Newswire - Thu Jan 29, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that its board of directors has declared that the regular, quarterly dividends to be paid to its stockholders in 2015 will be $0.15 per share of common stock, for a total of $0.60 for the full year.
PDLI: 7.28 (+0.03)
A Sad Reality: 3 of Healthcare's Top 5 Dividends Probably Aren't Sustainable
Sean Williams, The Motley Fool - Motley Fool - Wed Jan 28, 6:34AM CST
Source: Flickr user Sean McMenemy. Dividend stocks are the cornerstone of many of the best retirement portfolios. Not only do dividends provide a payment that shareholders in a stock can take to the bank, but when reinvested, these dividends'...
TBPH: 18.51 (+0.28), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), PDLI: 7.28 (+0.03)
Cramer's Lightning Round - No Panic Over Gilead (1/20/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Jan 21, 2:32PM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, January 20. Bullish calls: Perrigo Company (NYSE: PRGO ): "I think it’s a bad cold and flu season and I think Perrigo’s stock should be...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), YHOO: 44.42 (+0.50), PRGO: 150.90 (+0.22), GILD: 101.90 (+1.10), PDLI: 7.28 (+0.03), SCHW: 29.13 (-0.83), BABA: 89.05 (+1.95)
'Mad Money' Lightning Round: I Want You to Own Perrigo
at The Street - Wed Jan 21, 5:00AM CST
Cramer likes Morgan Stanley over Charles Schwab and Yahoo! over Alibaba.
AMBA: 50.71 (-4.46), BIIB: 391.66 (-0.45), CY: 14.76 (+0.01), PRGO: 150.90 (+0.22), SWKS: 81.85 (-0.57), CELG: 115.88 (+0.16), MS: 36.78 (-0.12), PDLI: 7.28 (+0.03), YHOO: 44.42 (+0.50), GILD: 101.90 (+1.10), REGN: 402.40 (+0.66), BABA: 89.05 (+1.95), SCHW: 29.13 (-0.83)
Jim Cramer's 'Mad Money' Recap: Here Are Today's Real Headlines
at The Street - Tue Jan 20, 7:04PM CST
Cramer puts the blame for today's morning market decline squarely on today's headlines, which had nothing good to say about anything.
BIIB: 391.66 (-0.45), PRGO: 150.90 (+0.22), DAL: 44.50 (-0.31), LQ: 21.59 (unch), YHOO: 44.42 (+0.50), JNJ: 99.62 (+1.18), IBM: 160.40 (+1.88), REGN: 402.40 (+0.66), CREE: 37.51 (+0.08), BHI: 64.31 (+1.93), SCHW: 29.13 (-0.83), AMBA: 50.71 (-4.46), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), HAL: 44.19 (+1.42), WFC: 55.33 (+0.47), CELG: 115.88 (+0.16), MS: 36.78 (-0.12), PDLI: 7.28 (+0.03), NFLX: 466.10 (+9.37), GILD: 101.90 (+1.10), WDAY: 91.84 (+0.67), STI: 41.57 (+0.01), BABA: 89.05 (+1.95)
3 Buy-Rated Dividend Stocks To Check Out: RHP, MIC, PDLI
at The Street - Fri Jan 09, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
MIC: 76.58 (+1.26), RHP: 57.51 (+0.15), PDLI: 7.28 (+0.03)
9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides
Fredrik Arnold - at Seeking Alpha - Sun Jan 04, 1:11AM CST
KND: 19.68 (-0.38), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), HLS: 45.01 (+0.30), MR: 27.19 (+0.15), SEM: 14.32 (+0.11), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), TRIB: 17.30 (-0.12), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
3 Biotech Stocks With a Higher Profit Margin Than Gilead Sciences, Inc.
Sean Williams, The Motley Fool - Motley Fool - Sat Jan 03, 10:16AM CST
Source: StockMonkeys.com via Flickr. It's been a truly transformative year for Gilead Sciences and its shareholders. Even taking into consideration the latest swoon in Gilead's share price tied to the approval of AbbVie 's Viekira Pak and...
GILD: 101.90 (+1.10), ADMS: 16.98 (+0.03), ABBV: 58.05 (+1.00), ENTA: 33.30 (-0.44), PDLI: 7.28 (+0.03)
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
PR Newswire - Thu Dec 18, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Geron Corporation (NASDAQ: GERN), PDL BioPharma Inc. (NASDAQ: PDLI), Cytori Therapeutics Inc. (NASDAQ: CYTX), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 17, 2014, surged as the Dow Jones Industrial Average finished at 17,356.87, up 1.69% and the NASDAQ Composite closed at 4,644.31, up 2.12%. The S&P 500 finished the session 2.04% higher at 2,012.89. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Index ended the day at 791.66, up 1.90%, with the index advancing 6.28% in the previous three months. Register for your complimentary reports on these five stocks at:
NAVB: 1.60 (unch), CYTX: 0.47 (unch), GERN: 3.03 (unch), ARIA: 7.35 (+0.45), PDLI: 7.28 (+0.03)
PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:10PM CST
PDL BioPharma (PDLI) estimates revenues to increase 41% from the year-ago period to roughly $158 million in the fourth quarter of 2014.
BIIB: 391.66 (-0.45), NVS: 102.20 (-0.17), PDLI: 7.28 (+0.03)
PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million
PR Newswire - Wed Dec 10, 3:02PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately $158 million, as compared with actual revenue of $112 million for the fourth quarter of 2013, an approximate 41 percent increase.
PDLI: 7.28 (+0.03)
Momentum Indicators for Biotech Equities - PDL BioPharma, Geron, Celldex Therapeutics, XOMA Corp., and Juno Therapeutics
PR Newswire - Mon Feb 09, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: PDL BioPharma Inc. (NASDAQ: PDLI), Geron Corporation (NASDAQ: GERN), Celldex Therapeutics Inc. (NASDAQ: CLDX), XOMA Corporation (NASDAQ: XOMA), and Juno Therapeutics Inc. (NASDAQ: JUNO). Free research report on PDL BioPharma can be accessed at http://get.Investor-Edge.com/pdf/?c=PDL%20Bio...amp;s=PDLI. On Friday, February 06, 2015, the NASDAQ Composite ended at 4,744.40, down 0.43%, the Dow Jones Industrial Average declined 0.34%, to finish the day at 17,824.29, and the S&P 500 closed at 2,055.47, down 0.34%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 806.81, down 0.84%, while the index has advanced 4.07% in the last three months. Register for your complimentary reports at the links given below.
GERN: 3.03 (unch), CLDX: 20.97 (+0.53), JUNO: 40.52 (+0.18), XOMA: 3.41 (-0.01), PDLI: 7.28 (+0.03)
PDL BioPharma: Beware The 8% Dividend
Dave Dierking, CFA - at Seeking Alpha - Fri Feb 06, 12:07PM CST
BIIB: 391.66 (-0.45), PDLI: 7.28 (+0.03), NVS: 102.20 (-0.17)
6.73% Edge For 5 Healthcare Lowest-Priced, High-Yield January Dividend Dogs
Fredrik Arnold - at Seeking Alpha - Thu Feb 05, 6:43PM CST
SNN: 35.82 (-0.28), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), SNY: 49.42 (+0.82), PDLI: 7.28 (+0.03)
10 Hardy Healthcare Dividend Dogs Hit 20% Mean January Upsides
Fredrik Arnold - at Seeking Alpha - Wed Feb 04, 7:53PM CST
KND: 19.68 (-0.38), BDX: 143.71 (+0.72), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), AMGN: 153.48 (+0.30), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), MR: 27.19 (+0.15), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), TRIB: 17.30 (-0.12), TEVA: 56.77 (-0.58), ABBV: 58.05 (+1.00), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
PDL BioPharma to Present at Upcoming Investor Conferences
PR Newswire - Wed Feb 04, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the following upcoming conferences.
PDLI: 7.28 (+0.03)
PDL BioPharma to pay USD0.15 per share dividend per quarter
M2 - Fri Jan 30, 11:15PM CST
The board of directors of PDL BioPharma (NasdaqGS
DLI), a monoclonal antibodies company, declared on Thursday that it will pay a regular, quarterly dividend of USD0.15 per share of its common stock. PDLI: 7.28 (+0.03)
Buy These Top 3 Buy-Rated Dividend Stocks Today: ENLK, PDLI, KMI
at The Street - Thu Jan 29, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
KMI: 41.97 (+0.21), PDLI: 7.28 (+0.03), ENLK: 28.62 (+0.25)
PDL BioPharma declares $0.15 dividend
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 6:22AM CST
PDLI: 7.28 (+0.03)
PDL BioPharma Announces 2015 Regular Quarterly Dividends
PR Newswire - Thu Jan 29, 6:00AM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that its board of directors has declared that the regular, quarterly dividends to be paid to its stockholders in 2015 will be $0.15 per share of common stock, for a total of $0.60 for the full year.
PDLI: 7.28 (+0.03)
A Sad Reality: 3 of Healthcare's Top 5 Dividends Probably Aren't Sustainable
Sean Williams, The Motley Fool - Motley Fool - Wed Jan 28, 6:34AM CST
Source: Flickr user Sean McMenemy. Dividend stocks are the cornerstone of many of the best retirement portfolios. Not only do dividends provide a payment that shareholders in a stock can take to the bank, but when reinvested, these dividends'...
TBPH: 18.51 (+0.28), THRX: 14.85 (+1.00), GSK: 47.94 (+1.99), PDLI: 7.28 (+0.03)
Cramer's Lightning Round - No Panic Over Gilead (1/20/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Jan 21, 2:32PM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, January 20. Bullish calls: Perrigo Company (NYSE: PRGO ): "I think it’s a bad cold and flu season and I think Perrigo’s stock should be...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), YHOO: 44.42 (+0.50), PRGO: 150.90 (+0.22), GILD: 101.90 (+1.10), PDLI: 7.28 (+0.03), SCHW: 29.13 (-0.83), BABA: 89.05 (+1.95)
'Mad Money' Lightning Round: I Want You to Own Perrigo
at The Street - Wed Jan 21, 5:00AM CST
Cramer likes Morgan Stanley over Charles Schwab and Yahoo! over Alibaba.
AMBA: 50.71 (-4.46), BIIB: 391.66 (-0.45), CY: 14.76 (+0.01), PRGO: 150.90 (+0.22), SWKS: 81.85 (-0.57), CELG: 115.88 (+0.16), MS: 36.78 (-0.12), PDLI: 7.28 (+0.03), YHOO: 44.42 (+0.50), GILD: 101.90 (+1.10), REGN: 402.40 (+0.66), BABA: 89.05 (+1.95), SCHW: 29.13 (-0.83)
Jim Cramer's 'Mad Money' Recap: Here Are Today's Real Headlines
at The Street - Tue Jan 20, 7:04PM CST
Cramer puts the blame for today's morning market decline squarely on today's headlines, which had nothing good to say about anything.
BIIB: 391.66 (-0.45), PRGO: 150.90 (+0.22), DAL: 44.50 (-0.31), LQ: 21.59 (unch), YHOO: 44.42 (+0.50), JNJ: 99.62 (+1.18), IBM: 160.40 (+1.88), REGN: 402.40 (+0.66), CREE: 37.51 (+0.08), BHI: 64.31 (+1.93), SCHW: 29.13 (-0.83), AMBA: 50.71 (-4.46), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), HAL: 44.19 (+1.42), WFC: 55.33 (+0.47), CELG: 115.88 (+0.16), MS: 36.78 (-0.12), PDLI: 7.28 (+0.03), NFLX: 466.10 (+9.37), GILD: 101.90 (+1.10), WDAY: 91.84 (+0.67), STI: 41.57 (+0.01), BABA: 89.05 (+1.95)
3 Buy-Rated Dividend Stocks To Check Out: RHP, MIC, PDLI
at The Street - Fri Jan 09, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
MIC: 76.58 (+1.26), RHP: 57.51 (+0.15), PDLI: 7.28 (+0.03)
9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides
Fredrik Arnold - at Seeking Alpha - Sun Jan 04, 1:11AM CST
KND: 19.68 (-0.38), VIVO: 19.15 (+0.16), PETS: 15.57 (-0.05), PFE: 34.64 (-0.23), GSK: 47.94 (+1.99), MSA: 46.51 (+0.21), HLS: 45.01 (+0.30), MR: 27.19 (+0.15), SEM: 14.32 (+0.11), PDLI: 7.28 (+0.03), SNN: 35.82 (-0.28), AZN: 69.96 (+0.20), MRK: 58.81 (-0.07), TRIB: 17.30 (-0.12), THRX: 14.85 (+1.00), SNY: 49.42 (+0.82)
3 Biotech Stocks With a Higher Profit Margin Than Gilead Sciences, Inc.
Sean Williams, The Motley Fool - Motley Fool - Sat Jan 03, 10:16AM CST
Source: StockMonkeys.com via Flickr. It's been a truly transformative year for Gilead Sciences and its shareholders. Even taking into consideration the latest swoon in Gilead's share price tied to the approval of AbbVie 's Viekira Pak and...
GILD: 101.90 (+1.10), ADMS: 16.98 (+0.03), ABBV: 58.05 (+1.00), ENTA: 33.30 (-0.44), PDLI: 7.28 (+0.03)
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
PR Newswire - Thu Dec 18, 8:15AM CST
Investor-Edge has initiated coverage on the following equities: ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Geron Corporation (NASDAQ: GERN), PDL BioPharma Inc. (NASDAQ: PDLI), Cytori Therapeutics Inc. (NASDAQ: CYTX), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Wednesday, December 17, 2014, surged as the Dow Jones Industrial Average finished at 17,356.87, up 1.69% and the NASDAQ Composite closed at 4,644.31, up 2.12%. The S&P 500 finished the session 2.04% higher at 2,012.89. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Index ended the day at 791.66, up 1.90%, with the index advancing 6.28% in the previous three months. Register for your complimentary reports on these five stocks at:
NAVB: 1.60 (unch), CYTX: 0.47 (unch), GERN: 3.03 (unch), ARIA: 7.35 (+0.45), PDLI: 7.28 (+0.03)
PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:10PM CST
PDL BioPharma (PDLI) estimates revenues to increase 41% from the year-ago period to roughly $158 million in the fourth quarter of 2014.
BIIB: 391.66 (-0.45), NVS: 102.20 (-0.17), PDLI: 7.28 (+0.03)
PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million
PR Newswire - Wed Dec 10, 3:02PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately $158 million, as compared with actual revenue of $112 million for the fourth quarter of 2013, an approximate 41 percent increase.
PDLI: 7.28 (+0.03)
